Arena Pharmaceuticals in the development stages of Narcolepsy treatment
Written by: David Castillo on March 25th, 2010
Arena Pharmaceuticals in the development stages of Narcolepsy treatment | 
Arena Pharmaceuticals Inc., a biotech company, has announced that it is in the early stages of research and development of a potential narcolepsy and cataplexy treatment.
Narcolepsy is a renowned sleep disorder that is characterized by excessive daytime drowsiness. A person with narcolepsy often falls asleep during daytime activities, like work and school.
The clinical trial will be conducted on 72 healthy adults.
You must be logged in to post a comment.
Latest Headlines
- Link between insomnia and death is still not proven
- First NY Professional Sleep Medicine Conference To Be Held in Albany, NY Oct. 1-2, 2010: Medical Reporters Welcome
- More military vets suffer from sleep apnea
- Sleep Apnea Group, SleepSafe Driver, Hires John Hill As Senior Advisor
- Insomnia linked to premature death in men
- British Association for Psychopharmacology releases treatment guidelines for sleep disorders
- Sleep Insights opens new sleep center
- Continucare acquires sleep diagnostic center
- NorthBay Healthcare holds sleep lecture
- New mothers get enough sleep, just not good-quality sleep
- Vaccine linked to Narcolepsy
- New sleep apnea research reported from University of California, Department of Psychiatry
- Sleep Apnea Revealed website adds new content on Sleep Apnea Surgery
- New drug combats jet lag
- The Best Sleep Apnea Treatment: CPAP vs. Oral Appliances: A Question of Compliance and Effectiveness
In The News
Helping Australia Sleep—new sleep lab in Gold Coast
A doctor based in Queensland’s Gold
Sleep Group Solutions, Glidewell Laboratories Partner to Provide Education About Snoring/Sleep Apnea Preventive Care
[PRWEB] — Sleep Group Solutions (SGS)
Australian doctors link obesity to sleep disorders
Researchers recently reviewed the records of
Cephalon sues Apotex for sleep drug patent
Cephalon Inc. is suing Apotex Corp.